Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Benjamin L. Ebert, Alexander Tepper et al.|Science Translational Medicine|2021Cited by 257
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGürkan Mollaoglu, Brian D. Brown, Alexander Tepper et al.|Cell|2024Cited by 99
Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic MalignanciesAline Renneville, Benjamin L. Ebert, Jessica A. Gasser et al.|Blood Cancer Discovery|2021Cited by 46
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growthJaime Mateus-Tique, Brian D. Brown, Ashwitha Lakshmi et al.|Cancer Cell|2026Cited by 5
Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancerChiara Falcomatà, Brian D. Brown, Sebastian R. Nielsen et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1